← Leaderboards
David Eavarone
Siamab Therapeutics, Inc.
$1,499,399
Attributed
$1,499,399
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,499,399 · 1
By mechanism
N44$1,499,399 · 1
Top collaborators
No co-investigators on record.
Most similar at Siamab Therapeutics, Inc.
Same institution · by research overlap
- Ana Paula Galvao Da Silva$222,319
Others in their field
Top investigators on “Antibody-Drug Conjugates”
- David S Perlin · Hackensack University Medical Center$11,429,593
- John M Maris · Children'S Hosp Of Philadelphia$8,904,495
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
- Roland Bruno Walter · Fred Hutchinson Cancer Center$8,109,765
- Donald W. Kufe · Dana-Farber Cancer Inst$8,108,689
- Timothy Jensen Henrich · University Of California, San Francisco$6,547,723
Research focus
Antibody-Drug ConjugatesAntigensCancer CellCancer RelapseCancer Stem CellCarbohydratesCell SurfaceCell TypeCellular StructuresClinically RelevantCross ReactivityCytotoxicDisease RemissionGenerationsIn VivoKillingsMalignant NeoplasmsMonoclonal AntibodiesNovel StrategiesNovel TherapeuticsProductionResistanceSafetySmall Business Innovation Research Grant